Epigral Ltd
NSE:EPIGRAL

Watchlist Manager
Epigral Ltd Logo
Epigral Ltd
NSE:EPIGRAL
Watchlist
Price: 1 856.35 INR -3.03% Market Closed
Market Cap: 80.1B INR
Have any thoughts about
Epigral Ltd?
Write Note
EPIGRAL
/
Income Statement
/
Revenue

Epigral Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epigral Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Epigral Ltd
NSE:EPIGRAL
Revenue
₹19.3B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Supreme Industries Ltd
NSE:SUPREMEIND
Revenue
₹103.7B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
10%
Tata Chemicals Ltd
NSE:TATACHEM
Revenue
₹149.9B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
-1%
Deepak Nitrite Ltd
NSE:DEEPAKNTR
Revenue
₹80.8B
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Berger Paints India Ltd
NSE:BERGEPAINT
Revenue
₹112.7B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
10%
Solar Industries India Ltd
NSE:SOLARINDS
Revenue
₹64.5B
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Epigral Ltd
Glance View

Market Cap
77.1B INR
Industry
Chemicals

Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.

EPIGRAL Intrinsic Value
1 774.95 INR
Overvaluation 4%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Epigral Ltd's Revenue?
Revenue
19.3B INR

Based on the financial report for Mar 31, 2024, Epigral Ltd's Revenue amounts to 19.3B INR.

What is Epigral Ltd's Revenue growth rate?
Revenue CAGR 3Y
33%

Over the last year, the Revenue growth was -12%. The average annual Revenue growth rates for Epigral Ltd have been 33% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.